Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
Singular Genomics Systems, Inc. (NASDAQ: OMIC) had its price target raised by analysts at UBS Group AG from $0.40 to $0.50. They now have a "neutral" rating on the stock.
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results